Premium
Donor evaluation in the era of HIV‐positive organ transplantation: The importance of the infectious diseases specialist
Author(s) -
HemmersbachMiller Marion,
Wood Robert P.,
Wolfe Cameron R.
Publication year - 2020
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.15921
Subject(s) - medicine , organ procurement , organ transplantation , intensive care medicine , organ donation , human immunodeficiency virus (hiv) , transplantation , kidney transplantation , infectious disease (medical specialty) , immunology , disease
A 61‐year‐old female with well‐controlled human immunodeficiency virus (HIV) and end‐stage renal disease was on the kidney transplant waitlist awaiting an organ offer, including from HIV‐positive donors through the HIV Organ Policy Equity (HOPE) Act. We present three different scenarios where HIV‐positive donor offers were evaluated for this one recipient, discuss the donor evaluation process, explain where the infectious diseases provider fits in this scheme, and describe the challenges encountered by organ procurement organizations. This is the first case under the HOPE Act at our center where discovery of an HIV‐specific issue led to a turndown of an organ offer.